INDIVIDUALIZATION OF LEVODOPA THERAPY

被引：7

作者：

BIANCHINE, JR

SUNYAPRIDAKUL, L

机构：

[1] TEXAS TECH UNIV, SCH MED, DEPT PHARMACOL & EXPTL THERAPEUTICS, LUBBOCK, TX 79409 USA

[2] TARBOR PARKINSONS DIS RES INST, LUBBOCK, TX USA

来源：

关键词：

D O I：

10.1016/S0025-7125(16)32103-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1071 / 1081

页数：11

共 50 条

[41] LEVODOPA THERAPY IN STRIATONIGRAL DEGENERATION
ANDREWS, JM
[J]. LANCET, 1972, 2 (7767): : 88 - &
[42] New developments in levodopa therapy
LeWitt, PA
Nyholm, D
[J]. NEUROLOGY, 2004, 62 (01) : S9 - S16
[43] DYSKINESIAS DURING LEVODOPA THERAPY
TOLOSA, ES
MARTIN, WE
COHEN, HP
[J]. LANCET, 1975, 1 (7921): : 1381 - 1382
[44] LEVODOPA THERAPY IN STRIATONIGRAL DEGENERATION
WEINMANN, RL
[J]. LANCET, 1972, 2 (7781): : 828 - &
[45] BRUXISM RELATED TO LEVODOPA THERAPY
MAGEE, KR
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 214 (01): : 147 - &
[46] Pharmacogenetics of Breast Cancer: Toward the Individualization of Therapy
Chang, Jenny C.
Hilsenbeck, Susan G.
Fuqua, Suzanne A. W.
[J]. CANCER INVESTIGATION, 2009, 27 (07) : 699 - 703
[47] EFFECT OF ANTACID ON LEVODOPA THERAPY
LAU, E
WATERMAN, K
GLOVER, R
SCHULZER, M
CALNE, DB
[J]. CLINICAL NEUROPHARMACOLOGY, 1986, 9 (05) : 477 - 479
[48] SUSTAINED LEVODOPA THERAPY IN PARKINSONISM
HUNTER, KR
SHAW, KM
LAURENCE, DR
STERN, GM
[J]. LANCET, 1973, 2 (7835): : 929 - 931
[49] INDIVIDUALIZATION OF CYCLOSPORINE THERAPY IN RENAL-TRANSPLANTATION
LEE, SF
YANG, WC
LOONG, CC
KING, KL
LIN, MF
[J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (04) : 1917 - 1919
[50] INDIVIDUALIZATION OF DRUG-THERAPY FOR PARKINSONIAN PATIENT
BECEIRO, J
BIANCHINE, JR
DUNN, J
FLEMENBAUM, A
GORDON, WH
KING, S
LAMAR, C
RYBURN, FM
SUNYAPRIDAKUL, L
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 233 (11): : 1198 - 1201